Tags |
|
|
Links |
|
|
Advice You - Enron Commodity Trading was Not Original
If one were to go an annual report for El Paso Energy from 2000; they would find on page 11 of the shareholders report a picture of their 80,000 square foot trading floor, with 700 merchant staff. Enron many thought had in f
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
act originated this; once upon a time claiming to be the largest in the world energy trading floor. So it was not new for Enron have come up with the concept, yes as far as trading floors for energy were concerned they did b
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
uild a bigger one. It was not totally innovative for them to have more traders at that point, not even very innovative to trade other things like; lumber futures to Del Webb or Pulte Homes or US Homes, or bandwidth or water
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
rights on top of their oil and gas trading and pipeline over capacity.
Trading the raw energy itself had been done before and so had the trading of environmental credits and contracts. That is an obvious and viable way to r
Trading the raw energy itself had been done before and so had the trading of environmental credits and contracts. That is an obvious and viable way to r
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
duce pollution through free enterprise proven efficiencies. The El Paso –Merchant Energy Group’s 2000 earnings before taxes was 960 million, 1999 it was 329 million and in 1998 it exceeded 293 million. That group traded LNG,
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
Power generation, financial services, coal and oil and gas and power assets. They also had global networks division, which was in the telecommunications business. Of course a simple look at El Paso Energy shows although the
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
y profited most from trading they were grounded by owning and acquiring pipelines, refining, drilling, oil field services, storage of product, and other real life services. On page 48, 49, 50, 51 and 52 of the 2000 annual re
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ort you will see about 15 partnerships and limited partnerships being used for all kinds of stuff. The whole report contains not less than 90 subsidiaries and limited partnerships with all kinds of sweet heart deals of stock
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
swaps and stock options and voting rights.
So Enron took normal industry type methods and really worked the system. Taking what was working well to the benefit of the user and industry and increasing it ten folf. Of course
So Enron took normal industry type methods and really worked the system. Taking what was working well to the benefit of the user and industry and increasing it ten folf. Of course
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
if you look at any railroad company they do the same thing it has been going on since Rockefeller days. I am not sure the Enron thing did not go further because it was bigger. If it was making money it would not have matter
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
d and it would have been business as usual, yet with the market driving it down in its final days and the stock plummeting and the serious junk credit rating down grade, of course now then it was all illegal. Perhaps the big
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
gest issue was the hiding of transparency along with creative book keeping with their friends at A. Anderson and the fa?ade which followed.
When El Paso merged with Coastal everything was forgotten and the company moved on
When El Paso merged with Coastal everything was forgotten and the company moved on
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
. What if Dynenergy merged with Enron and then all the old data of Enron was gone? And the Global Crossing Quest Deal had been a go, then what? What if GE had merged with Honeywell, maybe they would not be in dire straights.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
It seems the idea here is to run up the stock and look good on paper even though you are running on fumes and barrowed to the hilt and then sell at the top and forget about it. Well this time the greatest escape plan fell s
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ort and this time it was serious. In the case of the pre-merger audit with El Paso Energy and the Coastal Corporation, then changed to El Paso CGP Corporation for the merger the audits were done by separate companies. PriceW
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
aterHouseCooper did el Paso Energy and Deloitte & Touche LLP did The Coastal Corporation.
Yet whatever the overlap it is simply historical data, and who is to say if either company was as financially stable as it was prior
Yet whatever the overlap it is simply historical data, and who is to say if either company was as financially stable as it was prior
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
to the whole? Think if Enron and Dynenergy would have merged and all those little partnerships had been able to cash in at Dynenergy. WOW, talk about a run on the bank that would have been. I wonder how many LLCs of Enron co
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
tained board members of Dynenergy, that would sure add fire to the flame. Maybe none, but what if? What if the merger took place and know one knew? What would our country look like today? We would not have had Sarbaines Oxle
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
y, we would have less regulation, less attacks from attorneys generals on business and industry. We would have less off shoring of corporations, less outsourcing of jobs and we would have never lost 7 trillion in our stock m
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
arket. Privatizing one-third social security would not be an issue, everyone would want in. We would have more confidence in our markets and less worry of being passed by China as the leader of the free world. Think about it
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/4909/adviceyou-Enron-Commodity-Trading-was-Not-Original.html">Enron Commodity Trading was Not Original</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/4909/adviceyou-Enron-Commodity-Trading-was-Not-Original.html]Enron Commodity Trading was Not Original[/url]
Related Articles:
Products Need Better Instruction Booklets For the Mechanically Challenged
How A Business Growth Specialist Can Turn Your Business Into A Success
7 Marketing Ideas to Expand Your Customer Base and Profits
Bookmark it:
|